Water Island Capital’s Turning Point Therapeutics, Inc. Common Stock TPTX Stock Holding History

Water Island Capital’s Portfolio TPTX Stock Details TPTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-369,417	Closed	-$27.8M	–	117
2022 Q2	$27.8M	Buy	+369,417	New	+$16.4M	1.74%	25

Water Island Capital's TPTX Position: Q3 2022 in Review

Water Island Capital sold out of Turning Point Therapeutics, Inc. Common Stock (TPTX) in Q3 2022, closing a stake of 369,417 shares — an estimated $27.8M sold.

Water Island Capital first reported a position in TPTX in Q2 2022 and held it in 1 quarter. The position peaked at $27.8M in Q2 2022. 0 funds tracked by Wall St. Rank hold TPTX as of Q3 2022.

Water Island Capital reported no remaining Turning Point Therapeutics, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
Water Island Capital sold 369,417 Turning Point Therapeutics, Inc. Common Stock shares in Q3 2022, an estimated $27.8M.
Water Island Capital first reported a position in Turning Point Therapeutics, Inc. Common Stock in Q2 2022 and held it in 1 quarter.
Water Island Capital's Turning Point Therapeutics, Inc. Common Stock position peaked at $27.8M in Q2 2022.
0 funds tracked by Wall St. Rank held Turning Point Therapeutics, Inc. Common Stock as of Q3 2022.

Based on Water Island Capital's 13F filing for Q3 2022, filed 14 Nov 2022.